Gray, Phillip J

The opportunity cost of androgen suppression in locally advanced prostate cancer. [electronic resource] - Asian journal of andrology May 2013 - 356-7 p. digital

Publication Type: Journal Article; Comment

1745-7262

10.1038/aja.2012.166 doi


Adenocarcinoma--therapy
Androgen Antagonists--therapeutic use
Antineoplastic Agents, Hormonal--therapeutic use
Bone Density Conservation Agents--therapeutic use
Brachytherapy
Diphosphonates--therapeutic use
Humans
Imidazoles--therapeutic use
Leuprolide--therapeutic use
Male
Prostatic Neoplasms--therapy
Quality of Life